Alveolar/bronchiolar neoplasms in the 3.0 mg/kg dose group of female mice were significantly increased.
UCP2 levels in MT−/− mice were significantly lower compared to MT+/+ mice treated with Dox.
Cholesterol and ascorbic acid content in ovaries of crude extract-treated mice were significantly elevated.
The measured radioactivities in the bone and liver of atherosclerotic mice were significantly lower than in the control mice.
Fasting blood glucose levels in type 2 diabetic mice were significantly decreased after administration of the extract.
The phenylalanine concentrations in cerebral cortices of PKU mice were significantly higher than those in wild-type control mice.
In vivo experiments revealed that platinum accumulations in kidney of mice were significantly less compared to cisplatin.
After 4, 8 and 12 weeks, motor and sensory functional recovery in mice were significantly better in the iPS group.
Moreover, the levels of serum IgA, IgG, and IgM in CMZ-treated mice were significantly lower than those in PBS-treated mice.
Ventricular escape rhythms in HCN2-ADRB2 mice were significantly faster than in sham mice at day 15 after ablation and later.
The numbers of deep or secondary capillaries in air-reared Nrf2−/− mice were significantly decreased, when compared to Nrf2+/+ mice at P9 (P = 0.0082).
